4 Einträge gefunden

1. Daratumumab, Bortezomib, and Dexamethasone for Treatment of Patients with Relapsed or Refractory Multiple Myeloma and Severe Renal Impairment:Results from the Phase 2 GMMG-DANTE Trial

   1. Leypoldt, Lisa B
   2. Gavriatopoulou, Maria
   3. Besemer, Britta
   4. Salwender, Hans
   5. Raab, Marc S
   6. Nogai, Axel
   7. Khandanpour, Cyrus

   2023 - Forschungsinformationssystem des UKE - frei zugänglich
2. Selective elimination of immunosuppressive T cells in patients with multiple myeloma

   1. Awwad, Mohamed H S
   2. Mahmoud, Abdelrahman
   3. Bruns, Heiko
   4. Echchannaoui, Hakim
   5. Kriegsmann, Katharina
   6. Lutz, Raphael
   7. Raab, Marc S

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
3. Cystic transformation of focal lesions after therapy is associated with remission but adverse outcome in myeloma

   1. Merz, Maximilian
   2. Hielscher, Thomas
   3. Mai, Elias Karl
   4. Seckinger, Anja
   5. Hose, Dirk
   6. Jauch, Anna
   7. Sauer, Sandra

   2019 - Forschungsinformationssystem des UKE - frei zugänglich
4. Clinical spectrum of females with HCCS Mutation: from no clinical signs to a neonatal lethal form of the microphthalmia with linear skin defects (MLS) syndrome

   1. van Rahden, Vanessa A
   2. Rau, Isabella
   3. Fuchs, Sigrid
   4. Kosyna, Friederike K
   5. de Almeida, Hiram Larangeira
   6. Fryssira, Helen
   7. Isidor, Bertrand

   2014 - Forschungsinformationssystem des UKE - frei zugänglich